Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laurie Genest
Institution:
Porsolt (France)
Observed institution:
Porsolt (France)
ORCID:
0000-0002-1960-1506
Observed ORCID:
0000-0002-1960-1506
OpenAlex ID:
A5041739929
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response
2022
·
Tristan Rupp
, Laurie Genest
, et al.
·
Translational Oncology
·
77
PDF
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
2020
·
Tristan Rupp
, Océane Pelouin
, et al.
·
Translational Oncology
·
32
PDF
A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity
2022
·
Tristan Rupp
, Christophe Legrand
, et al.
·
Cancers
·
18
PDF
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models
2022
·
Tristan Rupp
, Solène Debasly
, et al.
·
International Journal of Molecular Sciences
·
17
PDF
Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models
2023
·
Mélodie Davy
, Laurie Genest
, et al.
·
Cancers
·
14
PDF
Preclinical evaluation of the efficacy and safety of temozolomide in a murine glioblastoma model
2026
·
Sonia Goineau
, Elise Esneault
, et al.
·
Journal of Pharmacological and Toxicological Methods
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models
2026
·
Pauline Gousseau
, Laurie Genest
, et al.
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
PDF
Show more works
View as search
Works count:
7
Citation count:
158
H-index:
5
I10-index:
5
Year
Topic
Type
